Surveys have found that vaccine distrust and objection remain high in Indonesia, even as the government rolled out the second stage of its COVID-19 inoculation program on Feb. 17.
As Indonesia rolls out its COVID-19 inoculation program for second priority recipients, public doubt remains a challenge alongside the limited vaccine supply.
The latest survey by the Centre for Strategic and International Studies-Jakarta (CSIS) found that 42.5 percent of respondents in the nation’s capital said they either strongly or moderately distrusted the efficacy of COVID-19 vaccines. In the cultural hub of Yogyakarta, the figure was 29.5 percent.
In Jakarta, 40 percent of all respondents said they did not want to be vaccinated, while 27.5 percent of respondents in Yogyakarta said the same.
"These figures are not ideal, even more so at a time when the second stage of the vaccination program is being rolled out for essential workers and the vulnerable age group," CSIS researcher Noory Oktarhiza said when the survey findings were released on Thursday.
"There must be information dissemination and hard work to make people believe in COVID-19 vaccines," Noory added.
Share your experiences, suggestions, and any issues you've encountered on The Jakarta Post. We're here to listen.
Thank you for sharing your thoughts. We appreciate your feedback.
Quickly share this news with your network—keep everyone informed with just a single click!
Share the best of The Jakarta Post with friends, family, or colleagues. As a subscriber, you can gift 3 to 5 articles each month that anyone can read—no subscription needed!
Get the best experience—faster access, exclusive features, and a seamless way to stay updated.